PMC:7408073 / 103977-104159 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3575","span":{"begin":59,"end":62},"obj":"Gene"},{"id":"3576","span":{"begin":67,"end":71},"obj":"Gene"},{"id":"3585","span":{"begin":140,"end":144},"obj":"Species"},{"id":"3588","span":{"begin":117,"end":126},"obj":"Chemical"},{"id":"3596","span":{"begin":72,"end":85},"obj":"Disease"}],"attributes":[{"id":"A3575","pred":"tao:has_database_id","subj":"3575","obj":"Gene:59272"},{"id":"A3576","pred":"tao:has_database_id","subj":"3576","obj":"Gene:59272"},{"id":"A3585","pred":"tao:has_database_id","subj":"3585","obj":"Tax:10116"},{"id":"A3588","pred":"tao:has_database_id","subj":"3588","obj":"MESH:C446481"},{"id":"A3596","pred":"tao:has_database_id","subj":"3596","obj":"MESH:D006948"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"to reduce production of Ang I, the necessary fuel for both ACE and ACE2 hyperactivity and their detrimental effects. Aliskiren treatment in rats has been shown to upregulate both AT1"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T55","span":{"begin":145,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"to reduce production of Ang I, the necessary fuel for both ACE and ACE2 hyperactivity and their detrimental effects. Aliskiren treatment in rats has been shown to upregulate both AT1"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T80351","span":{"begin":45,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A85320","pred":"chebi_id","subj":"T80351","obj":"http://purl.obolibrary.org/obo/CHEBI_33292"}],"text":"to reduce production of Ang I, the necessary fuel for both ACE and ACE2 hyperactivity and their detrimental effects. Aliskiren treatment in rats has been shown to upregulate both AT1"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T167","span":{"begin":72,"end":85},"obj":"Phenotype"}],"attributes":[{"id":"A167","pred":"hp_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/HP_0000752"}],"text":"to reduce production of Ang I, the necessary fuel for both ACE and ACE2 hyperactivity and their detrimental effects. Aliskiren treatment in rats has been shown to upregulate both AT1"}